Results of laboratory tests are shown in Table 1 ... with proteinuria-reducing agents (angiotensin-converting–enzyme inhibitors, angiotensin-receptor blockers, or sodium–glucose cotransporter ...

Abstract We investigated the short-term and sustained hormonal and renal effects of angiotensin II ... than that observed with 50 mg (Table 2). The results of the present study demonstrate that the ...

Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease 2.0 ... there were no major differences in baseline characteristics between the two arms (table 1). Overall, 92% ...

Table 3. Angiotensin converting enzyme inhibitors to treat hypertension. The most common side effects of ACE-Is include renal dysfunction, hyperkalemia, and cough. ACE-Is are contraindicated during ...

Table S2 summarizes the demographics and clinical characteristics ... 6MHW indicates six-minute hall walk test; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; ARNi, angiotensin ...

and inhibitors of the renin-angiotensin system (ACE inhibitors and angiotensin-II receptor blockers). Lipid-lowering drugs included statins, fibrates and ezetimibe, and antiplatelet drugs aspirin and ...

The increasingly widespread use of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs ... all of which have more common causes (table 1); a lack of understanding ...

At the second visit, the 3518 (67.5%) eligible patients were randomised in a 2×3 design to receive monotherapy with the first-line drug (calcium channel blockers, angiotensin-converting enzyme ...

Currently, there is evidence supporting the use of either an angiotensin receptor blocker or an angiotensin-converting enzyme inhibitor in the primary-prevention context. However, in the secondary ...

Before receiving a kidney transplant, patients with autosomal dominant polycystic kidney disease often undergo a nephrectomy. But there hasn’t been clear guidance on who’s a good candidate ...